These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 12934994

  • 1. Fluoxetine augmentation with olanzapine for treatment of chronic resistant depression in an elderly patient: a case report.
    Detweiler MB, Trinkle DB.
    J Clin Psychiatry; 2003 Jul; 64(7):851-2. PubMed ID: 12934994
    [No Abstract] [Full Text] [Related]

  • 2. An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses.
    Matthews JD, Bottonari KA, Polania LM, Mischoulon D, Dording CM, Irvin R, Fava M.
    J Clin Psychiatry; 2002 Dec; 63(12):1164-70. PubMed ID: 12523877
    [Abstract] [Full Text] [Related]

  • 3. Olanzapine augmentation for trichotillomania.
    Ashton AK.
    Am J Psychiatry; 2001 Nov; 158(11):1929-30. PubMed ID: 11691706
    [No Abstract] [Full Text] [Related]

  • 4. Influence of fluoxetine on olanzapine pharmacokinetics.
    Gossen D, de Suray JM, Vandenhende F, Onkelinx C, Gangji D.
    AAPS PharmSci; 2002 Nov; 4(2):E11. PubMed ID: 12102620
    [Abstract] [Full Text] [Related]

  • 5. Fluoxetine and olanzapine for resistant depression.
    Benazzi F.
    Am J Psychiatry; 2002 Jan; 159(1):155-6. PubMed ID: 11772722
    [No Abstract] [Full Text] [Related]

  • 6. Adjunctive use of olanzapine in mood disorders: five case reports.
    Weisler RH, Ahearn EP, Davidson JR, Wallace CD.
    Ann Clin Psychiatry; 1997 Dec; 9(4):259-62. PubMed ID: 9511951
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Olanzapine augmentation of fluoxetine in the treatment of refractory obsessive-compulsive disorder.
    Potenza MN, Wasylink S, Longhurst JG, Epperson CN, McDougle CJ.
    J Clin Psychopharmacol; 1998 Oct; 18(5):423-4. PubMed ID: 9790164
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
    Sanger TM, Grundy SL, Gibson PJ, Namjoshi MA, Greaney MG, Tohen MF.
    J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
    [Abstract] [Full Text] [Related]

  • 11. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder.
    Thase ME, Corya SA, Osuntokun O, Case M, Henley DB, Sanger TM, Watson SB, Dubé S.
    J Clin Psychiatry; 2007 Feb; 68(2):224-36. PubMed ID: 17335320
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High-dose olanzapine therapy in schizophrenia.
    Alao AO, Armenta WA, Yolles JC.
    Ann Pharmacother; 1999 Nov; 33(11):1228. PubMed ID: 10573326
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M.
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [Abstract] [Full Text] [Related]

  • 18. Improving identification of treatment effectiveness in bipolar disorders.
    Bowden CL.
    Bipolar Disord; 2003 Apr; 5(2):77-8. PubMed ID: 12680895
    [No Abstract] [Full Text] [Related]

  • 19. The combination of olanzapine and fluoxetine in mood disorders.
    Shelton RC.
    Expert Opin Pharmacother; 2003 Jul; 4(7):1175-83. PubMed ID: 12831342
    [Abstract] [Full Text] [Related]

  • 20. Combination of olanzapine and divalproex for agitation in individuals with profound mental retardation.
    Olson DA, Ingram W, Mann JR.
    J Clin Psychopharmacol; 2002 Oct; 22(5):529-30. PubMed ID: 12352281
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.